No two patients are the same, so often care teams can’t predict a treatment outcome from one patient to the next. That’s where biomarker testing comes in: the first step in personalized medicine.
Biomarker tests help physicians identify specific treatment options a patient will respond to best based on biologic factors. The problem? The testing isn’t accessible for all patients.
Hilary Gee Goeckner of the American Cancer Society Cancer Action Network shares why biomarker testing is so critical, the health equity implications, and how to expand access through policy. Plus, Alecia Mandal shares how biomarker testing allowed her to receive immunotherapy for her colorectal cancer, which she credits to her current health.
Dr. Robert Goldberg, “Dr. Bob,” Co-Founder and Vice President of the Center for Medicine in the Public Interest
Kate Pecora, Field Correspondent, Patients Rising
Alecia Mandal, colorectal cancer advocate
Melissa Strader, Patient Correspondent
The successful patient is one who can get what they need when they need it. We all know insurance slows us down, so why not take matters into your own hands? Our Navigator is an online tool that allows you to search a massive network of health-related resources using your zip code so you get local results. Get proactive and become a more successful patient right now at PatientsRisingConcierge.org
Have a question or comment about the show, or want to suggest a show topic or share your story as a patient correspondent?
Drop us a line: email@example.com
The views and opinions expressed herein are those of the guest(s)/ author(s) and do not reflect the official policy or position of Patients Rising.